His most unexpected recovery led Feldenkrais to conclude that his physical condition was not the only factor influencing how ...

The market for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) was valued USD 968 Million in 2017 which is anticipated to reach USD 2,020.6 Million by 2030.

MS patients in the U.S. with Medicaid coverage have worse disease outcomes compared with those who have private insurance, a ...